Dr Scott T. Tagawa is the Richard A. Stratton Associate Professor in Hematology and Oncology and Associate Professor of Clinical Medicine & Urology at Weill Cornell Medicine, and an Associate Attending Physician at the NewYork–Presbyterian/Weill Cornell Medical Center in New York, NY, USA. He is also Medical Director of the Clinical Trials Office and Associate Director of Clinical Research for the Division of Hematology and Medical Oncology at the Meyer Cancer Center in New York, and Chair of the US Clinical Study Evaluation (scientific review) Committee for Cancer.
Previous to joining Weill Cornell, Dr Tagawa was Assistant Professor of Medicine and Associate Program Director for the Fellowship Training Program at Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai) in New York, and Director of Genitourinary Oncology for the Division of Hematology/Oncology and Medical Oncology at the Deane Prostate Health and Research Center of Mount Sinai School of Medicine.
As Medical Director of the Genitourinary Oncology Research Program at Weill Cornell Medicine, his research focuses on clinical and translational investigations in genitourinary tumours, thrombosis in malignancy, and drug development in prostate cancer (with a particular interest in prostate-specific membrane antigen theranostics). He is also Weill Cornell’s principal investigator for the Alliance for Clinical Trials in Oncology, serving both on the board of directors and as a funded member of the Genitourinary Committee for the network.
Dr Tagawa is a member of the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology, serves on the editorial boards of many journals, is a member of numerous national and international medical and scientific societies, and has been named on multiple ‘top doctor’ award lists.
EM-25383- Date of preparation: December 2019